Table 2.
Assessment of inflammatory and endocrine biomarkers.
13-May-2021 | Reference values | ||
---|---|---|---|
Cytokines in semen | TNF | 30.6 | 0.0–2.0a |
(pg/mL) | IL-1β | 24.0 | 0.0–12.0a |
IL-6 | 99.2 | 2.0–20.0a | |
IL-8 | 2120.9 | 850.0–1910.0a | |
IFNγ | 0.00 | 0.0–10.0a | |
IL-10 | 0.00 | 0.0–10.0a | |
IL-17 | 8.2 | 0.0–19.8a | |
Serum/plasma hormones | Total testosterone (ng/dL) | 403 | 245–1500b |
Bioavailable testosterone (ng/dL) | 245 | 91–337b | |
Free testosterone (ng/dL) | 9.10 | 5.71–17.90b | |
FSH (mUI/mL) | 4.8 | 1.0–12.0b | |
LH (mUI/mL) | 4.4 | 1.5–9.2b | |
Prolactin (ng/mL) | 8.1 | 4.5–21.5b | |
17β-Estradiol (pg/mL) | 18 | 10–60b | |
Cortisol 8.00 a.m. (μg/dL) | 15.4 | 5.0–25.0b | |
Post-Dexamethasone Cortisol (μg/dL) | 0.53 | ≤1.70b | |
TSH (μUI/mL) | 1.57 | 0.4–4.0b |